- active not recruitingPHASE2
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
This study is testing a new medicine called sibeprenlimab for Sjögren's disease. We want to see if it helps reduce symptoms and if it's safe to use. Patients will either get the new medicine or a dummy medicine, alongside their usual care.
United States · Argentina · Bulgaria - recruitingPHASE1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
This study is looking at a new medicine called CLN-978 for people with Sjögren's disease. It's an early-stage study to see how safe it is and how well it works. The medicine is given as an injection under the skin.
United States · France · Germany